ITLN1 and heart failure: With respect to myocardial remodelling and heart failure, there is emerging evidence that omentin functions as an antihypertrophic factor following myocardial insult and that it may serve as a significant predictor of the development of left ventricular hypertrophy, at least in patients with Type 2 diabetes [84].